We therefore conducted a comprehensive meta-analysis to investigate the significance of PD-L1 expression as a prognostic marker and to determine the relation of PD-L1 expression to clinicopathological features and driver mutations in lung cancer patients. The gene discussed is CD274; the disease is lung carcinoma.